US Patent Issued to SANOFI on June 23 for "Imidazo[1,2-b[1,2,4triazol derivatives for use in therapy" (French Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,487, issued on June 23, was assigned to SANOFI (Paris).

"Imidazo[1,2-b[1,2,4triazol derivatives for use in therapy" was invented by Antonio Almario (Paris), Danielle De Peretti (Paris) and Amelie Dommergue (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a compound of the formula (I) or a pharmaceutically acceptable salt thereof: wherein: R1 represents a hydrogen atom, a halogen atom, or a (C1 C4)hydroxyalkyl group, R2 represents a (C1-C6)alkyl group, and R3 represents a hydrogen atom, a (C1-C4)alkyl group or a halogen atom, and Ar represents a divalent aromatic ring or a (C5-C11) heteroarylene group. It further...